Abstract:BackgroundSystemic sclerosis (SSc) is a multi-organ autoimmune disease characterized by skin fibrosis. Internal organ involvement is heterogeneous. It is unknown whether disease mechanisms are common across all involved affected tissues or if each manifestation has a distinct underlying pathology.MethodsWe used consensus clustering to compare gene expression profiles of biopsies from four SSc-affected tissues (skin, lung, esophagus, and peripheral blood) from patients with SSc, and the related conditions pulmonary fibrosis (PF) and pulmonary arterial hypertension, and derived a consensus disease-associate signature across all tissues. We used this signature to query tissue-specific functional genomic networks. We performed novel network analyses to contrast the skin and lung microenvironments and to assess the functional role of the inflammatory and fibrotic genes in each organ. Lastly, we tested the expression of macrophage activation state-associated gene sets for enrichment in skin and lung using a Wilcoxon rank sum test.ResultsWe identified a common pathogenic gene expression signature—an immune–fibrotic axis—indicative of pro-fibrotic macrophages (MØs) in multiple tissues (skin, lung, esophagus, and peripheral blood mononuclear cells) affected by SSc. While the co-expression of these genes is common to all tissues, the functional consequences of this upregulation differ by organ. We used this disease-associated signature to query tissue-specific functional genomic networks to identify common and tissue-specific pathologies of SSc and related conditions. In contrast to skin, in the lung-specific functional network we identify a distinct lung-resident MØ signature associated with lipid stimulation and alternative activation. In keeping with our network results, we find distinct MØ alternative activation transcriptional programs in SSc-associated PF lung and in the skin of patients with an “inflammatory” SSc gene expression signature.ConclusionsOur results suggest that the innate immune system is central to SSc disease processes but that subtle distinctions exist between tissues. Our approach provides a framework for examining molecular signatures of disease in fibrosis and autoimmune diseases and for leveraging publicly available data to understand common and tissue-specific disease processes in complex human diseases.

Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis

Immune Cell Dysregulation As a Mediator of Fibrosis in Systemic Sclerosis

Role of Epigenetics in the Pathogenesis of Systemic Sclerosis

Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential

Current Concepts on the Pathogenesis of Systemic Sclerosis

T-cells and B-cells in systemic sclerosis

The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis

Pathogenesis of systemic sclerosis-current concept and emerging treatments

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis

Unfolding the Pathogenesis of Systemic Sclerosis Through Epigenomics

Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities

The Epigenetic Regulation of Scleroderma and Its Clinical Application

Distinct T cell chromatin landscapes in scleroderma subtypes

New insights into CD4(+) T cell abnormalities in systemic sclerosis.

Systematic Approach to Understanding the Pathogenesis of Systemic Sclerosis

Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis

Research Progress in Epigenetic Studies on Systemic Sclerosis

Systemic Sclerosis: Genetics and Epigenetics

Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights

The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis

Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches